Best HR Catalyst Consulting Podcasts (2025)

1
A European CDR Purchasing Programme 26:58

8d ago26:58

26:58

A European CDR Purchasing Programme for Permanent Carbon Removal? Sounds too good to be true? Well, it may become a reality soon. On May 21st, the European Commission held a dedicated workshop on “A Purchasing Programme for CRCF Permanent Carbon Removal Credits”. As stated in its own excellent pre-read, Europe will need to fund CDR with up to €6 bi…

1
Public Subsidies + Carbon Credits: The winning combo? - with Erik Rylander 25:40

11d ago25:40

25:40

Many projects want to blend public funding with revenue from voluntary carbon markets as carbon removal scales up. Meanwhile, governments have different approaches to it. And sceptics keep questioning whether it makes sense in the first place - what about additionality, corresponding adjustments, and real climate impact? We’re excited to welcome Er…

1
Can we bank on Canada’s new PM to deliver carbon promises? - with Na'im Merchant 27:04

23d ago27:04

27:04

Against all odds, the Liberal Party just won the Canadian general elections. Mark Carney’s party explicitly campaigned to turn Canada into a global leader in carbon dioxide removal. Canada plans to do so by - among other things - extending its investment tax credit to 2035, supporting a broad range of CDR tech, and introducing dedicated CDR targets…

1
EU ETS: Is this the most important consultation of the year? 27:43

1M ago27:43

27:43

It's out: the European Commission published a consultation to gather feedback on what the world's largest emission trading system - the EU ETS - should look like after 2031. For carbon removals, integration into the EU ETS represents one of the most promising paths to predictable demand at scale. Whether and how that will happen is still up for deb…

1
CO₂: Waste or commodity? - with Rachael Moore 27:00

1M ago27:00

27:00

Are we scrubbing the smokestacks and skies of a waste gas, or creating a valuable resource for a net-zero world? As carbon management technologies like CCS, CCU, DACCS, and BECCS advance, policymakers and markets are narrowing down on CO₂’s role. In this CDR Policy Scoop, we dive into: What happens if we treat CO₂ only as waste? ⁠What is the real p…

1
CBAM: The carbon removal catalyst? - with Dan Maleski 27:50

2M ago27:50

27:50

How can the EU's Carbon Border Adjustment Mechanism help scale carbon dioxide removal? Designed to put a price on imported carbon and prevent leakage, but could it also act as a catalyst for scaling CDR? This CDR Scoop cuts through the noise to explore this critical link. We're digging deep to uncover the potential synergies and challenges. To ensu…

1
SHOWDOWN: Biochar vs Direct Air Capture - with Martin Freimüller 26:08

2M ago26:08

26:08

A fun, interactive, first-of-a-kind live debate with over 1000 attendees signed up. We picked two real heavyweights: DAC, the poster-child of CDR, with over 200 DAC companies founded to date. On the other hand, biochar, responsible for a whopping 84% of all durable CDR deliveries to date. In the DAC corner: Martin Freimüller is the Co-Founder and C…

1
Rethinking Net-Zero: Do international credits help or harm? 24:19

2M ago24:19

24:19

On March 31st, EU Climate Commissioner Wopke Hoekstra floated various ideas for how Europe’s expected 90% emission reduction target for 2040 could be achieved. One of them: letting EU countries purchase United Nations Article 6 credits to meet EU's 2040 climate target. Similar suggestions are currently being proposed by the upcoming German governme…

1
SBTi: Step forward or missed opportunity for CDR? - with Robert Höglund 27:43

3M ago27:43

27:43

8,000 companies have emission reduction targets validated by the Science Based Targets initiative. Only around 50 of them have so far purchased durable carbon removal. Imagine if all of them purchased CDR? The impact could be >50Mt of demand. Per year. Starting from 2030. On March 18th, the SBTi released the draft net-zero standard 2.0 which marks …

1
CORSIA vs ETS: What will actually clean up aviation? 28:25

3M ago28:25

28:25

Aviation is responsible for almost 1Gt of CO2 emissions, or 2.5% of global emissions. Up to 4% when accounting for non-CO2 climate warming effects. And demand is only going up: 3-4% year-on-year. Aviation is also notoriously hard to decarbonise: most hope is placed on sustainable aviation fuels (SAF). Given there will always be considerable residua…

1
Will the EU need twice as much CDR as expected? 27:47

3M ago27:47

27:47

Will the EU need 2x as much CDR? The highly anticipated 333-page milestone report on carbon removal by Europe's Scientific Advisory Board has landed, promising to be the most comprehensive analysis of CDR to date. Does this heavyweight report deliver the strategic guidance needed to shape effective EU CDR policy? What other crucial insights does it…

1
CDR at DoE is dead... or is it? - with Noah Deich 29:10

3M ago29:10

29:10

In February 2025, all probationary contract staff at the Department of Energy were terminated, including the most incredibly talented and experienced people who had turned the U.S. into a CDR powerhouse over the previous years. What does this - alongside the freezing of IRA and BIL funds - mean for CDR in the U.S. moving forward? How will DAC Hubs …

1
CDR into the EU ETS: Boom or doom? 28:05

4M ago28:05

28:05

Emission trading systems (ETS) are often touted as the largest potential source of demand for carbon dioxide removal (CDR), providing a large, predictable market worth billions. The EU ETS is by far the largest and most successful in the world, with its market size around 900 billion EUR and carbon price climbing over 80 EUR/t. 2025 is the time whe…

1
Like-For-Like: The policy silver bullet? - with Robert Höglund 27:16

4M ago27:16

27:16

In carbon removal policy circles, three simple words - like-for-like - seem to come up more and more. It is a simple and obvious concept that is actually incredibly complex and misunderstood. Robert Höglund joins Eve Tamme and Sebastian Manhart in exploring like-for-like as a concept, why it is becoming a core pillar of CDR policy design and what n…

1
How will the EU fund CDR? 26:46

4M ago26:46

26:46

On January 28th, the European Commission hosted a long-awaited workshop on public funding for permanent CDR. Expectations were high - maybe too high? What came out of it and what is lined up for funding of CDR in Europe? Both Eve (in person) and Sebastian (remote) attended, and are bringing you all the insights you need to know. Tune in to find out…

1
Trump’s Inauguration: What will happen to CDR in the US? - with Erin Burns 27:21

4M ago27:21

27:21

Donald J. Trump has been sworn in as the 47th President of the United States. As soon as he took office, executive orders were signed affecting all areas of the U.S. society and economy, including climate and CDR. Joined by Erin Burns, the Executive Director of the U.S.’ leading CDR nonprofit Carbon180, Eve Tamme and Sebastian Manhart try to make s…

1
Our 2025 CDR Policy Predictions 28:03

5M ago28:03

28:03

What will be the main themes and developments this year? 2025 will likely be the biggest year for CDR policy to date. Eve Tamme and Sebastian Manhart compared and discussed their top 5 predictions, covering national, regional, and global CDR policy. Tune in to get to know what to look out for in 2025. Show notes: Eve Tamme: LinkedIn and Website Seb…

1
The EU's 2040 Climate Target(s): What to expect? 29:45

5M ago29:45

29:45

The EU’s 2040 Climate Target(s): hope in difficult times or empty promises? In 2025, the European Union will attempt to formalise a binding target for emission reduction in 2040. This would complement the existing 55% reduction target for 2030 and a climate neutrality target for 2050. As of today, the European Commission plans to recommend an ambit…

1
CRCF: Did the EU get it right? 29:11

5M ago29:11

29:11

The CRCF - the gold standard for CDR certification? Some see it as the world's most important CDR policy, others just as an empty shell with no clear impact. In this CDR Policy Scoop, Eve Tamme and Sebastian Manhart dive into this hot topic they both feel very passionately about. Tune in to hear where it currently stands, what some of the sticking …

1
US Election: What does it mean for carbon removal? - with Jason Grillo 28:24

5M ago28:24

28:24

What will the Trump victory mean for CDR? Speculation is rife - is this the end of CDR in the U.S., a blessing in disguise, or simply not that important? In this CDR Policy Scoop, Eve Tamme and Sebastian Manhart are joined by the one and only Jason Grillo to dig into what this Republican trifecta of control over the White House, House of Congress, …

1
COP29: CDR’s big moment? 28:19

5M ago28:19

28:19

Will COP29 be the breakthrough COP for CDR? What a start! Article 6.4 standards were adopted on day 1 of COP29 in Baku, Azerbaijan. What does this actually mean, and what else can we expect? In this CDR Policy Scoop, Eve Tamme and Sebastian Manhart try to make sense of a topic that has generated a lot of excitement but also raised some serious ques…

1
Welcome to the CDR Policy Scoop 4:35

5M ago4:35

4:35

The CDR Policy Scoop, where we unpack carbon removal policy in 30 minutes or less. Punchy, unfiltered, to the point discussions on all hot developments in the sector. Listen in to go several levels deeper and beyond the analysis that you won't find anywhere else. Enjoy. Find out more: Eve Tamme: LinkedIn and Website Sebastian Manhart: LinkedIn and …

1
Biotech, Blockchain, and Building Companies with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners 34:28

6M ago34:28

34:28

This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights o…

1
Funding, Partnerships, and Growth: Strategies for Startup Biotech Success with Fractional Chief Business Officer Renee Williams 34:39

7M ago34:39

34:39

This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee shares her career path, insights into helping biotech startups secure funding and navigate partnerships, and the importance of adaptabl…

1
Trust, Teamwork, and Innovation, with Natalie Nairn, Co-founder and CEO of Cyclera Therapeutics 37:42

7M ago37:42

37:42

This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, whi…

1
The Science of Success: Transforming Scientific Concepts into Marketable Products with Stacy Frye, co-founder and CCO of Stimulus Bio 39:36

7M ago39:36

39:36

In this episode, I had an engaging conversation with Stacie Frye, co-founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how StimulusBio aids startups in operational and commercialization aspects, leveraging Stacie's unique journey across marketing, chemical en…

1
Small Offerings, Big Impact: Demystifying Micro-IPOs in Biotech with David Sans, Head of Healthcare Investment Banking at EF Hutton 37:13

8M ago37:13

37:13

This week, I had an insightful conversation with David Sans, PhD, FAARM, MBA, who heads healthcare investment banking at EF Hutton. We discussed the intricacies of different Public Offering strategies, including micro IPOs, which offer a unique avenue for biotech companies. David provides a deep perspective on the strategic implications of IPOs for…

1
Not All Who Wander Are Lost: with Iva Toudjarska, founder and CEO of Zeal Therapeutics 33:12

8M ago33:12

33:12

This week I had a great conversation with Iva Toudjarska, founder and CEO of Zeal Therapeutics. From earning a PhD in molecular biology to a solid scientific career at Alnylam, to working in venture capital, to selling a successful SaaS company, Iva’s career that’s set her up well to enjoy this new challenge – founding a baby biotech. Her expertise…

1
From Seed to Success: How MassBio is Boosting Biotech 43:58

8M ago43:58

43:58

This week I had a fun conversation with Jason Cordeiro, Chief Operating and Innovation Officer at MassBio. We dissect MassBio's newly announced five-year strategic plan that includes a multi-pronged set of initiatives aimed at advancing the biotech industry. From supporting early-stage startups to advocating for policy changes and fostering talent …

1
Building Biotechs Better: Inside LabCentral's Culture of Innovation with Mike LaRhette, Chief Business Officer at LabCentral 46:38

8M ago46:38

46:38

In this episode, we revisit a fun conversation with Mike LaRhette, Chief Business Officer at LabCentral. Mike outlines the essentials for startups, including funding, lab space, mentorship, and resources. He shares his journey from aspiring architect to an architect of biotech ecosystems, detailing his experiences with MassChallenge and LabCentral.…

1
How to Build a Lean, Mean Biotech Machine: with Bogdan Knezevic, founder of Kaleidoscope Bio 40:35

9M ago40:35

40:35

This week I spoke with Bogdan Knezevic, founder of Kaleidoscope Bio, about optimizing biotech workflows and achieving milestones efficiently. Bogdan shared insights into how his platform helps companies manage research and development processes, reducing operational inefficiencies and saving time, resources, and money. He discussed the importance o…

1
The Purpose of Employee Development 33:48

9M ago33:48

33:48

Employee development may be more important than ever in today’s changing job market. Employee development is mutually beneficial for both employees and businesses as employees improve existing competencies and develop new skills while supporting the goals of business and filling skill gaps. We are talking with our guest Christina Rossini about some…

1
Dream Big Dreams to Solve Big Problems: with Jon Hu, CEO and co-founder of Pepper Bio 39:40

10M ago39:40

39:40

This week I spoke with Jon Hu, CEO and co-founder of Pepper Bio, about his journey from pharma consulting and venture capital to founding a tech-enabled biotech company. Pepper Bio created an AI and machine learning platform accelerating drug discovery for untreatable diseases. In addition to the platform, Pepper is currently navigating their asset…

1
Grow by Experimenting with Cheri Ackerman, Cofounder & CEO of Concerto Biosciences 35:02

11M ago35:02

35:02

This week we chatted with Cheri Ackerman, PhD, Cofounder & CEO of Concerto Biosciences. During her postdoctoral work at MIT, she developed the groundbreaking kChip technology that led to the formation of Concerto Biosciences. We discuss the challenges and opportunities of building a company during the pandemic and the importance of learning the bus…

1
Better Communication in Biotech with Krysta Pellegrino 39:51

11M ago39:51

39:51

This week I sat down with Krysta Pellegrino, Chief Client Officer at Health+Commerce, a public relations and marketing agency specifically focused on healthcare. Krysta shared her unique perspective on how biotech companies can leverage communications strategies to tell their stories effectively, attract talent, and navigate complex challenges. She…

1
Empowering the Future: Why Science Club for Girls is Great for Biotech 39:39

11M ago39:39

39:39

In this episode, I had the privilege to interview Bonnie Bertolaet, Ph.D, Executive Director of Science Club for Girls, and Ashley Cooper, MS, MPhil, Curriculum Writer and Evaluation Manager at Science Club for Girls and former Co-Director of the Harvard Chapter of Science Club for Girls. Science Club for Girls aims to ignite excitement, confidence…

1
Company Values Masterclass with Lynn Walder, Founder & Principal of Executive Management Partners 43:34

11M ago43:34

43:34

In this episode, we had the pleasure of welcoming back Lynn Walder, our first repeat guest, to dive into the pitfalls and best practices of defining culture and core values for growing companies. There has been a shift in how companies invest in and operationalize culture over the past two decades. Lynn shares insights from her extensive experience…

1
Just Take the Leap: Founding and Growing Nanopath with Co-Founders Amogha Tadimety and Alison Burklund 28:24

12M ago28:24

28:24

Today, I had the opportunity to speak with Amogha Tadimety, PhD, CEO, and Alison Burklund, PhD, President & CTO, co-founders of Nanopath, an innovative company specializing in women’s health diagnostics. Both hailing from Dartmouth’s Thayer School of Engineering, Amogha and Alison walk us through the challenges and opportunities of founding a diagn…

1
Putting Culture at the Center 35:11

12M ago35:11

35:11

Let's don't make things more complicated than they really are. Having a great company culture can actually be rooted in the basics and made to be pretty simple. Today, we are looking at some of the foundational elements of a great culture that every organization should have at their center. Glen Morrell started his career in the Fortune 500 world, …

1
Navigating Frontier Technologies with Ben Hemani of Bison Ventures 30:33

12M ago30:33

30:33

In this episode, I sat down with Ben Hemani from Bison Ventures, a venture capital firm that invests in early-stage frontier technology companies. We explore his background in environmental engineering and his transition into the venture capital world, driven by a passion for technology and sustainability. Ben elaborates on the interconnected areas…

1
It Takes a Village to Raise a Biotech with Krisha Panchalingam, Director of Lab and Scientific Operations at Portal Innovations 30:01

1y ago30:01

30:01

This week I sat down with Krisha Panchalingham, Director of Lab and Scientific Operations at Portal Innovations. Krisha shares how she and her team support early-stage biotech companies through the operational intricacies of setting up labs, handling logistics, maintaining equipment, and complying with regulations. We also discuss the importance of…

1
How to Install a Recruiting Engine That Saves Time and Money with Carina Clingman, Founder and Principal of Recruitomics Consulting 36:31

1y ago36:31

36:31

This week, Carina Clingman, PhD, Founder and Principal of Recruitomics Consulting, outlines an actionable 3-Step framework to simplify the recruitment process and hire top-quality talent. The discussion covers common challenges faced by small companies, such as desperation hiring and inefficiencies, and offers solutions like implementing applicant …

1
Transforming Women's Health Through Innovation with Oriana Papin-Zoghbi, CEO and co-founder of AOA Dx 27:12

1y ago27:12

27:12

This week I chatted with Oriana Papin-Zoghbi, CEO and co-founder of AOA Dx. Oriana shares insights on the challenges of fundraising and the importance of building a network for startup success. She highlights her career shift from biochemistry to economics and international relations, finally leading to her involvement in women's health diagnostics…

1
Unlocking Leadership Potential in Biotech with Tony Martignetti, Founder and Chief Inspiration Officer of Inspired Purpose Partners 38:00

1y ago38:00

38:00

This week, I chatted with leadership advisor, speaker, entrepreneur, and podcast host Tony Martignetti, MBA, CPC, Founder, and Chief Inspiration Officer of Inspired Purpose Partners. We both agree there’s a critical need for more comprehensive coaching and support for leaders in the biotech industry. Drawing from his diverse career that spans from …

1
The Future of Genomic Storage with Heather E. Williams, COO of Cache DNA 33:05

1y ago33:05

33:05

In this episode, Heather E. Williams, PhD, MBA, MS, PgD, ErCLG, CG (ASCP) MB, the Chief Operating Officer of Cache DNA, chats about her career journey and the importance of always learning. Heather's passion for medicine and genetics has led her from childhood dreams of being like Dr. Quinn, Medicine Woman to training as a clinical laboratory genet…

1
Leaders as Change Agents with Catharine Smith, Executive Director of the Termeer Foundation 37:07

1y ago37:07

37:07

This week, we had a conversation with Catharine Smith - the Executive Director at the Termeer Foundation. Catharine is passionate about supporting biotech founders in growing patient-centric companies. We are thrilled about the Termeer Foundation and have been delighted to witness the Termeer Fellows thrive through the support, training, and commun…

1
From Dinos to Drugs with Isaac Stoner, CEO of Octagon Therapeutics 35:36

1y ago35:36

35:36

In this episode, we chatted with Isaac Stoner, M.B.A., the CEO of Octagon Therapeutics. Isaac is known for his expertise in building small companies and embarking on adventurous missions such as recovering airplane black boxes (yes, you read that correctly!). He also hosts a science enthusiast networking group in Cambridge, where attendees drink be…

1
Embracing Change: Lessons from a Career in Biotech with Kyriakos Economides, PhD 30:24

1y ago30:24

30:24

This week we sat down with Kyriakos Economides, PhD, VP of Translational Pharmacology at Werewolf Therapeutics. If there’s one constant in biotech, it’s change. We discussed the evolution of a career, rolling with the punches, and the importance of a solid clinical plan early in the drug development lifecycle. Kyriakos's favorite book: The Emperor …

1
Empowering Entrepreneurs with Leen Kawas, PhD, Managing General Partner at Propel Bio Partners 38:43

1y ago38:43

38:43

This week, we had an insightful conversation with Leen Kawas, PhD, Managing General Partner at Propel Bio Partners. She shared her journey from studying pharmacy to founding a successful company (with a great exit) and now running a venture fund. She emphasizes the business case for the importance of DEI in the company leadership and in clinical tr…

1
Bench to Boardroom with Andrew Fraley, PhD, CTO at Judo Bio & Entrepreneur in Residence at Atlas Venture 46:01

1y ago46:01

46:01

This week, we had the pleasure of chatting with Andrew Fraley, PhD, Entrepreneur in Residence with Atlas Venture. We chatted about his journey from bench chemist to entrepreneur, and some of the things he learned in the process. He also shared valuable insights on structuring a pitch deck for those on the funding trail. Tune in to learn from Andrew…

Podcasts Worth a Listen

HR Catalyst Consulting Podcasts

Podcasts Worth a Listen

Quick Reference Guide